Endocrinology News

Adults with type 2 diabetes may have a higher risk for developing nonarteritic anterior ischemic optic neuropathy while using semaglutide therapy than when they are not using the drug, according to findings from a retrospective study.

Better cardiovascular health significantly reduced the risk for bone fractures related to osteoporosis, according to results from a cross-sectional study.

Published results showed women who used systemic hormonal contraceptives, such as pills, patches, implants, injections and rings, had decreased incidences of ACL injuries vs. women who were not using contraceptives.

Children with overweight and obesity experienced notable improvements in health outcomes after participating in a lifestyle treatment program through a pediatric obesity clinic and local parks and recreation facility.

Adults with obesity who underwent Roux-en-Y gastric bypass achieved a greater excess BMI loss at 10 years compared with those who underwent a laparoscopic sleeve gastrectomy, according to data published in JAMA Surgery.

Glomerular hyperfiltration may increase CVD risks, including myocardial infarction and heart failure, for patients with type 2 diabetes, study data show.

Recently postmenopausal women with elevated blood pressure but no other CVD risk factors were more likely to develop white matter lesions 14 years later, regardless of short-term hormone therapy use, data show.

Less than 5% of hospitalized adults with type 2 diabetes received an SGLT2 inhibitor or GLP-1 before being discharged, according to data from a cohort study published in the Journal of Diabetes and Its Complications.

The FDA has approved two new biosimilars of denosumab to treat osteoporosis, increase bone mass, prevent skeletal-related events for people with multiple myeloma and other indications, Samsung Bioepis announced.